Anca Vasculitis

In this video, Rula Hajj-Ali, MD discusses the latest developments in the study and treatment of vasculitis.

LONG BEACH, Calif. — Hydralazine-induced autoimmune conditions may have a varied presentation, including drug-induced lupus or vasculitis, according to a speaker, here.

In this video, Audra Horomanski, MD, spoke with Healio about the impact vasculitis has on the management of pregnancy.

ROME — One-year results of the phase 2 ALTITUDE trial showed efficacy and safety of a one-time in-office injection of ABBV-RGX-314 for the treatment of diabetic retinopathy.

Glucocorticoids can do a lot of harm over time. In this episode, John Stone, MD, MPH, walks us through the Glucocorticoid Toxicity Index, a validated tool to measure steroid toxicity over time that we’ll be seeing more of in the future.

Avacopan yielded significantly better kidney function outcomes than prednisone in a cohort of patients with renal disease associated with anti-neutrophil cytoplasmic antibody vasculitis, according to data presented at ACR Convergence 2021.

Despite an ever-growing array of potential candidate biomarkers for antineutrophil cytoplasmic antibody-associated vasculitis, it can be a long journey from “bench work” to bedside, according to a presenter at ACR Convergence 2021.

So-called “COVID toes” and other cutaneous manifestations of the virus are not the only dermatologic challenges that a rheumatologist may face, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.

The American College of Rheumatology has released three new vasculitis treatment guidelines — for ANCA-associated vasculitis, giant cell arteritis and Takayasu arteritis, and polyarteritis nodosa — with a fourth expected soon.